UBC Therapeutics Initiative Best Evidence Webinar: ‘Medicine is Awesome’: A critical look at the factors that shape the definition of, and research on, depression and its treatment. Presented by Dr. Allen Shaughnessy, PharmD, School of Medicine, Tufts University, Boston, USA
Dr. Marnie Wilson is a Clinical Assistant Professor of Medicine (Internal Medicine) and a fellow in Critical Care Medicine at the University of British Columbia. Her research interest is in deprescription and the implementation of deprescription interventions, particularly in hospitalized patients and patients with complex multimorbidity. Dr Emily G. McDonald is an Associate Professor of […]
When challenged by complex cases involving people taking too many medications, we may ask: Can I stop any of these? Which should I stop first? Do I need to taper this drug? If so, how? What should I monitor for after stopping, and when? Many clinicians address these clinical questions successfully, improving outcomes for patients. […]
Dr. Erick Turner is a psychiatrist who previously worked at the Food and Drug Administration (FDA), reviewing applications from drug companies seeking to get their psychotropic drugs approved for the US market. There he learned that much efficacy and safety data does not get communicated transparently to doctors and patients. After coming to Oregon Health & […]
There are many good reasons for judicious prescribing: better patient care, lower costs for patients and healthcare systems and reduced burden on providers. Another important reason that many of us never consider is the environmental “pill burden”. Join this TI Best Evidence Webinar with Dr. Ilona Hale on Wednesday, March 15th to learn more about […]
When challenged by complex cases involving people taking too many medications, we may ask: Can I stop any of these? Which should I stop first? Do I need to taper this drug? If so, how? What should I monitor for after stopping, and when? Many clinicians address these clinical questions successfully, improving outcomes for patients. […]
Dr. Juan Erviti is a qualified hospital pharmacist in Pamplona, Navarra, Spain. His research activity is focused on pharmacoepidemiology and systematic reviews, and has published over 50 articles in high impact medical journals. He is the Director of the Navarre Cochrane Associate Center and a member of the Cochrane Hypertension satellite group in Spain. He […]
Featuring Cases by: Shauna Archer, NP (F) Victoria BC – Case #1: “Can deprescribing ameliorate postural hypotension in a man with complex mental health issues?” Marc Clark MD, FCFP, Edmonton AB – Cases #2 and #3: “Back from the ‘pre-dead’ – hospice patients who bounced back after deprescribing” LEARNING OBJECTIVES: By the end of the […]
When challenged by complex cases involving people taking too many medications, we may ask: Can I stop any of these? Which should I stop first? Do I need to taper this drug? If so, how? What should I monitor for after stopping, and when? Many clinicians address these clinical questions successfully, improving outcomes for patients. […]
When challenged by complex cases involving people taking too many medications, we may ask: Can I stop any of these? Which should I stop first? Do I need to taper this drug? If so, how? What should I monitor for after stopping, and when? Many clinicians address these clinical questions successfully, improving outcomes for patients. […]
In this TI Best Evidence webinar, Dr. Mark Horowitz will present the Maudsley Deprescribing Guidelines approach to deprescribing antidepressants and share insights about distinguishing between the withdrawal effects resulting from stopping antidepressants and the relapse of underlying conditions. He will also describe the method of hyperbolic tapering to stopping antidepressants. There will be an opportunity for participants to ask questions. […]
When challenged by complex cases involving people taking too many medications, we may ask: Can I stop any of these? Which should I stop first? Do I need to taper this drug? If so, how? What should I monitor for after stopping, and when? Many clinicians address these clinical questions successfully, improving outcomes for patients. […]
